A novel fully human anti-TIGIT and PVRIG bispecific antibody that elicits potent anti-tumor efficacy in pre-clinical studies.Shuang Dai,Weifeng Huang,Zhijun Yuan,Shaogang Peng,Jiayi Si,Chao Wang,Xiaoniu Miao,Yingda Xu,Joanne Sun,Xiaolin Liu,Andy Tsun,Tianhang ZhaiCANCER RESEARCH(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要